awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33758258-21C64AD1-42F4-448E-8EF4-6A269488F39C
Q33758258-21C64AD1-42F4-448E-8EF4-6A269488F39C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33758258-21C64AD1-42F4-448E-8EF4-6A269488F39C
Efficacy and safety of TACE in combination with sorafenib for the treatment of TACE-refractory advanced hepatocellular carcinoma in Chinese patients: a retrospective study.
P2860
Q33758258-21C64AD1-42F4-448E-8EF4-6A269488F39C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33758258-21C64AD1-42F4-448E-8EF4-6A269488F39C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
422f50834d63b494b41621f3782eef80193b519b
P2860
Sorafenib alone versus sorafenib combined with transarterial chemoembolization for advanced-stage hepatocellular carcinoma: results of propensity score analyses.